(Q38354680)

English

A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)

scientific article published on June 2, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV) (English)

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

molecular medicine

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

author name string

Yan Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Robert Anderson

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2 June 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744884

2 January 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03000446?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X03000446?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

19-20

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2500-2505

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines and cytokine-mediated pathology in RSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral respiratory tract infection and exacerbations of asthma in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma and the common cold: can viruses imitate worms?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulators and delivery systems for vaccination by mucosal routes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900044-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of primary infection and reinfection with respiratory syncytial virus

1

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

19

1 reference

10.1016/S0264-410X(03)00044-6

https://api.crossref.org/works/10.1016/S0264-410X(03)00044-6

2 January 2024

Identifiers

10.1016/S0264-410X(03)00044-6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38354680&oldid=2042948045"